Both the charts and the fundamentals agree.   Read More

Many analysts, lobbyists and industry executives have been saying for months that healthcare reform would probably end up being a net positive for the drug companies.    Read More

On Saturday, the House backed a health care bill that would expand coverage to nearly all Americans and bar insurance practices such as refusing to cover people with pre-existing medical conditions. How should investors be positioned? Bob Phillips, managing partner at Spectrum Management Group and Robert Zagunis, co-portfolio manager at Jensen Investment Management shared their insights.    Read More

Markets rose on Wednesday despite a weaker-than-expected reading on the services sector. Is the economy in the middle of a recovery and if so, how can investors play it? Bill Spiropoulos, CEO of CoreStates Capital Advisors and John Merrill, founder and CIO of Tanglewood Wealth Management shared their insights.    Read More

Dividends can be a way for investors to effectively safeguard returns during volatile times. Joseph Keating, CIO of Private Asset Management at RBC Bank shared some of his best dividend picks for investors.    Read More

On a day when the market is in full-tilt rally mode on the GDP number, shares of Dow component Merck and the company it's buying, Schering-Plough, are sliding. So, what gives?    Read More

A flood of companies have yet to report earnings throughout this week, so how should investors prepare their portfolios? Jason Pride, director of research at Haverford Investments, shared his views.    Read More

Meaning: shareholders. Here are two companies that delivered surprise quarters – but not in a good way.   Read More

Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!   Read More

Not all earnings are created equal. Find out which numbers matter most to the Fast Money traders!   Read More